PL3089735T3 - Trwała ciśnieniowa kompozycja roztworu aerozolowego kombinacji bromku glikopironium i formoterolu - Google Patents
Trwała ciśnieniowa kompozycja roztworu aerozolowego kombinacji bromku glikopironium i formoteroluInfo
- Publication number
- PL3089735T3 PL3089735T3 PL14825154T PL14825154T PL3089735T3 PL 3089735 T3 PL3089735 T3 PL 3089735T3 PL 14825154 T PL14825154 T PL 14825154T PL 14825154 T PL14825154 T PL 14825154T PL 3089735 T3 PL3089735 T3 PL 3089735T3
- Authority
- PL
- Poland
- Prior art keywords
- formoterol
- combination
- stable pressure
- glycopyrronium bromide
- aerosol solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/007—Mechanical counters
- A61M15/0071—Mechanical counters having a display or indicator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0086—Inhalation chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/22—Valves or arrangement of valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/22—Valves or arrangement of valves
- A61M2039/226—Spindles or actuating means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0238—General characteristics of the apparatus characterised by a particular materials the material being a coating or protective layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Filling Or Discharging Of Gas Storage Vessels (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13199784 | 2013-12-30 | ||
| PCT/EP2014/079259 WO2015101576A1 (en) | 2013-12-30 | 2014-12-23 | Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination |
| EP14825154.9A EP3089735B1 (en) | 2013-12-30 | 2014-12-23 | Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3089735T3 true PL3089735T3 (pl) | 2018-12-31 |
Family
ID=49886777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14825154T PL3089735T3 (pl) | 2013-12-30 | 2014-12-23 | Trwała ciśnieniowa kompozycja roztworu aerozolowego kombinacji bromku glikopironium i formoterolu |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US10596113B2 (pl) |
| EP (3) | EP3566694A1 (pl) |
| JP (2) | JP6563950B2 (pl) |
| KR (2) | KR101861119B1 (pl) |
| CN (2) | CN105848641B (pl) |
| AR (2) | AR098982A1 (pl) |
| AU (1) | AU2014375301C1 (pl) |
| BR (1) | BR112016014583B1 (pl) |
| CA (1) | CA2935305C (pl) |
| CL (1) | CL2016001653A1 (pl) |
| CY (1) | CY1120668T1 (pl) |
| DK (1) | DK3089735T3 (pl) |
| EA (1) | EA033227B1 (pl) |
| ES (1) | ES2687345T3 (pl) |
| GE (1) | GEP20186855B (pl) |
| HR (1) | HRP20181551T1 (pl) |
| HU (1) | HUE039513T2 (pl) |
| IL (1) | IL246498B (pl) |
| LT (1) | LT3089735T (pl) |
| MA (1) | MA39155A1 (pl) |
| MX (1) | MX368835B (pl) |
| MY (1) | MY182861A (pl) |
| PE (1) | PE20160997A1 (pl) |
| PH (1) | PH12016501268B1 (pl) |
| PL (1) | PL3089735T3 (pl) |
| PT (1) | PT3089735T (pl) |
| RS (1) | RS57687B1 (pl) |
| SA (1) | SA516371427B1 (pl) |
| SG (1) | SG11201605311UA (pl) |
| SI (1) | SI3089735T1 (pl) |
| TN (1) | TN2016000261A1 (pl) |
| TW (1) | TWI660747B (pl) |
| UA (1) | UA117845C2 (pl) |
| WO (1) | WO2015101576A1 (pl) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101747474B1 (ko) | 2009-12-23 | 2017-06-14 | 키에시 파르마슈티시 엣스. 피. 에이. | Ｃｏｐｄ용 에어로졸 제제 |
| TWI495468B (zh) | 2009-12-23 | 2015-08-11 | 吉斯藥品公司 | 治療慢性阻塞性肺病（ｃｏｐｄ）之醫藥組成物 |
| CN102665678B (zh) * | 2009-12-23 | 2014-07-02 | 奇斯药制品公司 | 用于copd的联合治疗 |
| WO2015101576A1 (en) * | 2013-12-30 | 2015-07-09 | Chiesi Farmaceutici S.P.A. | Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination |
| CN105848642A (zh) * | 2013-12-30 | 2016-08-10 | 奇斯药制品公司 | 格隆溴铵和福莫特罗组合的稳定的加压气雾剂溶液组合物 |
| WO2017093758A1 (en) | 2015-12-04 | 2017-06-08 | Mexichem Fluor S.A. De C.V. | Pharmaceutical composition |
| GB2545025A (en) * | 2015-12-04 | 2017-06-07 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
| US10098837B2 (en) | 2016-07-28 | 2018-10-16 | Chiesi Farmaceutici S.P.A. | Combination therapy for COPD |
| US10888546B2 (en) | 2016-09-19 | 2021-01-12 | Mexichem Fluor S.A. De C.V. | Pharmaceutical composition |
| CN107233311B (zh) * | 2017-06-27 | 2020-12-04 | 长风药业股份有限公司 | 一种以阿福特罗和格隆溴铵为活性成分的雾化剂及其制备方法 |
| WO2020070620A2 (en) * | 2018-10-01 | 2020-04-09 | 3M Innovative Properties Company | Formulation and aerosol canisters, inhalers, and the like containing the formulation |
| WO2020084549A1 (en) * | 2018-10-25 | 2020-04-30 | Glenmark Specialty S.A. | Nebulization composition comprising glycopyrrolate and formoterol |
| US20220241524A1 (en) * | 2019-07-12 | 2022-08-04 | Kindeva Drug Delivery L.P. | Aerosol formulation, canister, and inhaler containing the formulation, and method of use |
| EP4069189A1 (en) | 2019-12-02 | 2022-10-12 | Chiesi Farmaceutici S.p.A. | Stainles steel can for pressurised metered dose inhalers |
| GB2593283B (en) * | 2020-01-28 | 2023-09-13 | Chiesi Farm Spa | Pressurised metered dose inhalers comprising a buffered pharmaceutical formulation |
| WO2021165348A1 (en) | 2020-02-20 | 2021-08-26 | Chiesi Farmaceutici S.P.A. | Pressurised metered dose inhalers comprising a buffered pharmaceutical formulation |
| US20230270754A1 (en) | 2020-07-31 | 2023-08-31 | Chemo Research, S.L. | Combination therapy for inhalation administration |
| CN112051346A (zh) * | 2020-09-24 | 2020-12-08 | 珠海瑞思普利生物制药有限公司 | 一种同时测定茚达特罗和格隆溴铵含量的hplc方法 |
| AU2021356146A1 (en) | 2020-10-09 | 2023-05-04 | Chiesi Farmaceutici S.P.A. | A pharmaceutical formulation for pressurised metered dose inhaler |
| CN118475343A (zh) * | 2021-12-21 | 2024-08-09 | 凯西制药公司 | 填充在具有改善的耐湿性的吸入器中的干粉制剂 |
| CN116338014A (zh) * | 2021-12-23 | 2023-06-27 | 上海医药工业研究院有限公司 | 一种吸入用药物组合物的组分分离检测方法 |
| EP4531921A1 (en) | 2022-05-27 | 2025-04-09 | Chiesi Farmaceutici S.p.A. | A pharmaceutical formulation for pressurised metered dose inhaler |
| US20250302742A1 (en) | 2022-05-27 | 2025-10-02 | Chiesi Farmaceutici S.P.A. | A pharmaceutical formulation for pressurised metered dose inhaler |
| JP2025517808A (ja) | 2022-05-27 | 2025-06-10 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | 加圧式定量噴霧吸入器のための医薬製剤 |
| CN117679423A (zh) | 2022-09-05 | 2024-03-12 | 立生医药(苏州)有限公司 | 预防或治疗呼吸系统疾病的吸入用药物组合物 |
| WO2025179179A1 (en) * | 2024-02-23 | 2025-08-28 | Astrazeneca Ab | Triple combination therapy for copd |
| WO2026006658A1 (en) | 2024-06-27 | 2026-01-02 | Lupin Inc. | Stable pharmaceutical compositions for pressurized metered dose inhalers |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2956062A (en) | 1959-02-26 | 1960-10-11 | Robins Co Inc A H | Esters of amino alcohols |
| AU749697B2 (en) | 1998-08-04 | 2002-07-04 | Jagotec Ag | Medicinal aerosol formulations |
| US20060171899A1 (en) * | 1998-12-10 | 2006-08-03 | Akwete Adjei | Water-stabilized aerosol formulation system and method of making |
| IT1317720B1 (it) | 2000-01-07 | 2003-07-15 | Chiesi Farma Spa | Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani. |
| GB0008660D0 (en) | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
| AU5070100A (en) | 2000-05-22 | 2001-12-03 | Chiesi Farma Spa | Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| US20060257324A1 (en) | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
| US6750210B2 (en) * | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
| EP1241113A1 (en) * | 2001-03-12 | 2002-09-18 | CHIESI FARMACEUTICI S.p.A. | Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
| EP1321159A1 (en) | 2001-12-21 | 2003-06-25 | CHIESI FARMACEUTICI S.p.A. | Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices |
| US20040126325A1 (en) * | 2002-03-12 | 2004-07-01 | David Lewis | Medicinal aerosol solution formulation products with improved chemical stability |
| EP1718336B1 (en) | 2004-02-06 | 2008-06-25 | MEDA Pharma GmbH & Co. KG | Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases |
| JP4819699B2 (ja) | 2004-02-06 | 2011-11-24 | メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト | 喘息及びｃｏｐｄの長期間の治療のための抗コリン作用薬及びグルココルチコイドの組合せ剤 |
| CN100457087C (zh) * | 2004-02-27 | 2009-02-04 | 奇斯药制品公司 | 用于加压计量吸入器的稳定的药用溶液制剂 |
| GB0410399D0 (en) | 2004-05-10 | 2004-06-16 | Arakis Ltd | The treatment of respiratory disease |
| CN1950075A (zh) * | 2004-05-13 | 2007-04-18 | 奇斯药制品公司 | 化学稳定性改善的医用气溶胶制剂产品 |
| GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
| MX2007012084A (es) | 2005-03-30 | 2007-11-21 | Schering Corp | Medicamentos y metodos que combinan un anticolinergico, un corticosteroide y un agonista beta de accion prolongada. |
| GB0523653D0 (en) | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0523654D0 (en) | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0523655D0 (en) | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0523656D0 (en) | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| EP2201934A1 (en) * | 2008-12-23 | 2010-06-30 | CHIESI FARMACEUTICI S.p.A. | Tiotropium aerosol formulation products with improved chemical stability |
| WO2010144628A2 (en) * | 2009-06-09 | 2010-12-16 | Elevation Pharmaceuticals, Inc. | Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration |
| KR101747474B1 (ko) * | 2009-12-23 | 2017-06-14 | 키에시 파르마슈티시 엣스. 피. 에이. | Ｃｏｐｄ용 에어로졸 제제 |
| TWI495468B (zh) * | 2009-12-23 | 2015-08-11 | 吉斯藥品公司 | 治療慢性阻塞性肺病（ｃｏｐｄ）之醫藥組成物 |
| RU2567040C2 (ru) | 2009-12-23 | 2015-10-27 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Аэрозольная препаративная форма для лечения по поводу хронического обструктивного легочного заболевания |
| CN102665678B (zh) * | 2009-12-23 | 2014-07-02 | 奇斯药制品公司 | 用于copd的联合治疗 |
| RU2561570C2 (ru) | 2010-09-06 | 2015-08-27 | Кьези Фармасьютичи С.П.А. | Исполнительный механизм дозирующего ингалятора и дозирующий ингалятор |
| MX2013013440A (es) * | 2011-05-17 | 2014-06-05 | Pearl Therapeutics Inc | Composiciones, metodos y sistemas para suministro respiratorio de dos o mas agentes activos. |
| SG11201501434PA (en) | 2012-08-29 | 2015-03-30 | Chiesi Farma Spa | Aerosol inhalation device |
| CN105848642A (zh) * | 2013-12-30 | 2016-08-10 | 奇斯药制品公司 | 格隆溴铵和福莫特罗组合的稳定的加压气雾剂溶液组合物 |
| WO2015101576A1 (en) * | 2013-12-30 | 2015-07-09 | Chiesi Farmaceutici S.P.A. | Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination |
-
2014
- 2014-12-23 WO PCT/EP2014/079259 patent/WO2015101576A1/en not_active Ceased
- 2014-12-23 UA UAA201606910A patent/UA117845C2/uk unknown
- 2014-12-23 HU HUE14825154A patent/HUE039513T2/hu unknown
- 2014-12-23 KR KR1020187007444A patent/KR101861119B1/ko active Active
- 2014-12-23 CN CN201480071526.7A patent/CN105848641B/zh active Active
- 2014-12-23 LT LTEP14825154.9T patent/LT3089735T/lt unknown
- 2014-12-23 BR BR112016014583-6A patent/BR112016014583B1/pt active IP Right Grant
- 2014-12-23 CN CN202010180583.6A patent/CN111150728B/zh active Active
- 2014-12-23 KR KR1020167020695A patent/KR101861117B1/ko active Active
- 2014-12-23 EA EA201691126A patent/EA033227B1/ru active Protection Beyond IP Right Term
- 2014-12-23 PT PT14825154T patent/PT3089735T/pt unknown
- 2014-12-23 SI SI201430881T patent/SI3089735T1/sl unknown
- 2014-12-23 DK DK14825154.9T patent/DK3089735T3/en active
- 2014-12-23 EP EP19175726.9A patent/EP3566694A1/en active Pending
- 2014-12-23 AU AU2014375301A patent/AU2014375301C1/en active Active
- 2014-12-23 EP EP14825154.9A patent/EP3089735B1/en active Active
- 2014-12-23 HR HRP20181551TT patent/HRP20181551T1/hr unknown
- 2014-12-23 ES ES14825154.9T patent/ES2687345T3/es active Active
- 2014-12-23 SG SG11201605311UA patent/SG11201605311UA/en unknown
- 2014-12-23 PL PL14825154T patent/PL3089735T3/pl unknown
- 2014-12-23 CA CA2935305A patent/CA2935305C/en active Active
- 2014-12-23 MX MX2016008594A patent/MX368835B/es active IP Right Grant
- 2014-12-23 RS RS20181112A patent/RS57687B1/sr unknown
- 2014-12-23 JP JP2016561079A patent/JP6563950B2/ja active Active
- 2014-12-23 MY MYPI2016001207A patent/MY182861A/en unknown
- 2014-12-23 PE PE2016000968A patent/PE20160997A1/es unknown
- 2014-12-23 GE GEAP201814191A patent/GEP20186855B/en unknown
- 2014-12-23 TN TN2016000261A patent/TN2016000261A1/en unknown
- 2014-12-23 EP EP18171127.6A patent/EP3384898A1/en active Pending
- 2014-12-29 AR ARP140104938A patent/AR098982A1/es not_active Application Discontinuation
- 2014-12-29 TW TW103146043A patent/TWI660747B/zh active
- 2014-12-30 US US14/585,533 patent/US10596113B2/en active Active
-
2016
- 2016-06-28 PH PH12016501268A patent/PH12016501268B1/en unknown
- 2016-06-28 MA MA39155A patent/MA39155A1/fr unknown
- 2016-06-28 IL IL246498A patent/IL246498B/en active IP Right Grant
- 2016-06-28 SA SA516371427A patent/SA516371427B1/ar unknown
- 2016-06-28 CL CL2016001653A patent/CL2016001653A1/es unknown
- 2016-06-29 US US15/196,318 patent/US10617638B2/en active Active
-
2018
- 2018-09-11 CY CY181100949T patent/CY1120668T1/el unknown
-
2019
- 2019-07-25 JP JP2019136785A patent/JP6823118B2/ja active Active
-
2023
- 2023-08-17 AR ARP230102185A patent/AR130239A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3089735T3 (pl) | Trwała ciśnieniowa kompozycja roztworu aerozolowego kombinacji bromku glikopironium i formoterolu | |
| IL246502A0 (en) | Preparations containing solutions for pressure-stable sprays that include a mixture of glycopronium and formoterol | |
| LT3080100T (lt) | Lizinui specifinės demetilazės-1 inhibitoriai | |
| PL3453270T3 (pl) | Materiał generujący aerozol i urządzenia go zawierające | |
| FR3006556B1 (fr) | Atomiseur etanche | |
| BR112016000457A2 (pt) | Vedação nasal | |
| BR302013003484S1 (pt) | Configuração aplicada a umidificador | |
| HUE046520T2 (hu) | Hangmezõ dekomponált reprezentációinak tömörítése | |
| BR302013006509S1 (pt) | Configuração aplicada a esterilizador | |
| PL3030519T3 (pl) | Trójpierścieniowe związki benzoksaborolu i ich zastosowania | |
| BR302014002209S1 (pt) | Configuração aplicada em equipamento dispensador | |
| EP2934533A4 (en) | INHIBITORS OF THE RENAL KALIUM CHANNEL OF THE OUTER MEDULLA | |
| PL2674155T3 (pl) | Połączenie rezweratrolu i karboksymetyloglukanu | |
| FI20135069L (fi) | Puukappaleen uusi käyttö | |
| EP2958947A4 (en) | CONJUGATE CONNECTION AND USES THEREOF | |
| EP2910121A4 (en) | LIQUID INSECTICIDE COMPOSITION | |
| TH1601003861A (th) | องค์ประกอบสารละลายชนิดละอองลอยแบบอัดความดันที่เสถียรของการรวมกันของ ไกลโคไพร์โรเนียมโบรไมด์ และฟอร์โมเทอรอล | |
| TH1601003862A (th) | องค์ประกอบสารละลายชนิดละอองลอยแบบอัดความดันที่เสถียรของการรวมกันของ ไกลโคไพร์โรเนียมโบรไมด์ และฟอร์โมเทอรอล | |
| PT2956129T (pt) | Composições farmacêuticas que contêm dexcetoprofeno e tramadol | |
| TR201313940A1 (tr) | Selüloz bazlı hamostatik ve antiseptik materyal | |
| TH1401004951B (th) | สารรวมของสารประกอบออกฤทธิ์ | |
| TH1401007376A (th) | ไดอะซาสไปโรไซโคลแอลเคนและอะซาสไปโรไซโคลแอลเคนชนิดใหม่ | |
| UA26213S (uk) | Ковпачок аерозольного балона | |
| TH1601003676B (th) | วิธีการพันเเผ่นยาวเเละอุปกรณ์การพันแผ่นยาว | |
| TH1501001026A (th) | อุปกรณ์สูดละอองยา |